1292347

Glimepiride Related Compound D

United States Pharmacopeia (USP) Reference Standard

• 別名: 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[3-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide, 1-[[m-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea
• 実験式（ヒル表記法）: C₂₄H₃₄N₄O₅S
• CAS番号: 791104-62-6
• 分子量: 490.62
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: glimepiride
• メーカー／製品名: USP
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 2-8°C
• InChI: 1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-13-12-18-6-5-7-20(14-18)34(32,33)27-23(30)26-19-10-8-16(2)9-11-19/h5-7,14,16,19H,4,8-13,15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-
• InChI Key: XBXROPCBZLGQMA-RUCARUNLSA-N

詳細

詳細

この製品は薬局方標準品です。発行元の薬局方により製造・供給されています。詳しい情報は、発行元の薬局方のウェブサイトよりご確認ください。

アプリケーション

• Glucosamine substituted sulfonylureas: Research into glucosamine substituted sulfonylureas, including analogues of Glimepiride, highlights their potential in modulating the IRS-PI3K-PKC-AKT-GLUT4 insulin signaling pathway. This suggests new therapeutic avenues for diabetes management, specifically enhancing insulin sensitivity and glucose uptake (Suaifan et al., 2024).


• Insulin sensitivity and β-cell function study: Studies involving Glimepiride have examined its impact on insulin sensitivity and β-cell function over time, comparing it to other therapeutic agents. This research is crucial for understanding the differential effects of diabetes treatments, including those related to Glimepiride′s metabolites and impurities (Utzschneider et al., 2024).

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable